Firm
The firm reported a small uptick in overall revenue and profit per equity partner, while its IP team secured notable life sciences victories
Paul Ainsworth, who secured a settlement for his client in a patent dispute, says the case shows why medical claims by dietary supplement companies can threaten IP rights
Boies Schiller Flexner joins forces with Grünecker to target Skechers in Europe following US lawsuit
Helen Mutimer discusses how the firm’s IP advisory services are filling a gap in the market, and why life sciences work is soaring
Sponsored
Sponsored
-
Sponsored by LexOrbisManisha Singh and Neha Ruhela of LexOrbis highlight a High Court of Delhi ruling concerning an imitating product registered on the back of an existing registration -
Sponsored by Remfry & SagarRaashi Jain of Remfry & Sagar explains how the application of two trademark law principles by the High Court of Delhi played a key role in a victory for the Football Association Premier League
-
Sponsored by Patrinos & KilimirisConstantinos Kilimiris of Patrinos & Kilimiris draws on recent case law in noting that an applicant’s timely action fulfils the urgency requirement for the granting of a preliminary injunction
-
Sponsored by Tahota Law FirmCharles Feng, Mengyi Zhang, and Lian Xue of Tahota Law Firm consider what actions constitute the use of trademarks in China and explain how to reduce revocation risk concerning parts and internal components
-
Sponsored by InspicosWhile concrete definitions are still lacking, Peter Koefoed of Inspicos says patent applicants seeking protection for second medical uses of products could now find it easier to build their case
-
Sponsored by Wanhuida Intellectual PropertyJianhui Li of Wanhuida Intellectual Property reports on a ruling by the China National Intellectual Property Administration that could shed light on the patent examination standards concerning cutting-edge siRNA inventions
